Myotonic Dystrophy Overview
Learn About Myotonic Dystrophy
Myotonic dystrophy is part of a group of inherited disorders called muscular dystrophies. It is the most common form of muscular dystrophy that begins in adulthood.
Myotonic dystrophy type 1 is caused by mutations in the DMPK gene, while type 2 results from mutations in the CNBP gene. The protein produced from the DMPK gene likely plays a role in communication within cells. It appears to be important for the correct functioning of cells in the heart, brain, and skeletal muscles (which are used for movement). The protein produced from the CNBP gene is found primarily in the heart and in skeletal muscles, where it helps regulate the function of other genes.
Myotonic dystrophy affects at least 1 in 8,000 people worldwide. The prevalence of the two types of myotonic dystrophy varies among different geographic and ethnic populations. In most populations, type 1 appears to be more common than type 2. However, recent studies suggest that type 2 may be as common as type 1 among people in Germany and Finland.
Both types of myotonic dystrophy are inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In most cases, an affected person has one parent with the condition.
University Of Miami
Mario Saporta is a Neurologist in Miami, Florida. Dr. Saporta and is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy. His top areas of expertise are Charcot-Marie-Tooth Disease, Limb-Girdle Muscular Dystrophy Type 1A, Limb-Girdle Muscular Dystrophy, and Limb-Girdle Muscular Dystrophy Type 2B. Dr. Saporta is currently accepting new patients.
South Broward Hospital District
Karim Salame is a Neurologist in Aventura, Florida. Dr. Salame and is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy. His top areas of expertise are Peripheral Neuropathy, Axillary Nerve Dysfunction, Foot Drop, and Myasthenia Gravis. Dr. Salame is currently accepting new patients.
Neuroscience Consultants Llp
Luis Becerra-Cabal is a Neurologist and an Ophthalmologist in Aventura, Florida. Dr. Becerra-Cabal and is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy. His top areas of expertise are Cerebellar Degeneration, Stroke, Transient Ischemic Attack (TIA), and Migraine. Dr. Becerra-Cabal is currently accepting new patients.
Summary: Nearly two-third of patients with myotonic dystrophy type 2 (DM2) report that impaired cognition is among the most disabling symptoms and deeply affects their quality of life. Yet, relatively little is known about how DM2 affects brain structure and cognitive function as brain imaging studies in DM2 are extremely limited. This is a prospective, cross-sectional study of brain structure and function...
Summary: Myotonic dystrophy type 1 (DM1) is a neuromuscular disease characterized by multisystem manifestations. DM1 can affect the urinary system through the impact of the pelvic floor muscles (PFM). Urinary incontinence can occur in this situation and is often offset with compensatory measures without restoring the PFM function (e.g. sanitary pads). PFM training have already been shown to be effective in...
Published Date: July 01, 2020
Published By: National Institutes of Health